Evidence map›Paper›PMID 19673482›Full record

ArticleBiochemistry2009

Occidiofungin, a unique antifungal glycopeptide produced by a strain of Burkholderia contaminans.

Shi-En Lu, Jan Novak, Frank W Austin, Ganyu Gu, Dayna Ellis, Marion Kirk, Shawanda Wilson-Stanford, Marco Tonelli, Leif Smith

Abstract read
In one paragraph

Article in Biochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Genomic Basis of Lifestyle Divergence in Rice-AssociatedInternational journal of molecular sciences · 2026
    Article
  3. Biological control ofFrontiers in microbiology · 2026
    Article
  4. Review
  5. Review
  6. Review
  7. Isolation and Identification ofMicroorganisms · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Natural and engineered xylosyl products from microbial source.Natural products and bioprospecting · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Compilation of the Antimicrobial Compounds Produced byMolecules (Basel, Switzerland) · 2023
    Review
  18. Article
  19. Potential Biocontrol Activities ofPathogens (Basel, Switzerland) · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Shi-En LuMississippi State University, Department of Entomology, Mississippi State, Mississippi 39762, USA.
Jan Novak
Frank W Austin
Ganyu Gu
Dayna Ellis
Marion Kirk
Shawanda Wilson-Stanford
Marco Tonelli
Leif Smith
Mississippi State University · USUniversity of Alabama at Birmingham · USUniversity of Wisconsin–Madison · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Robert S Welner · 1985 to 2026
$165.9M
WATER DISTRIB:PHYSICAL PROPERT:PIZZA &LMPS MOZZARELLA CHEESES:EARLY STAGE MATURP41RR002301 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · PI MARKLEY, JOHN LUTE · 1985 to 2011
$13.0M
900 MHz NMR Spectrometer Biomolecular InvestigationsP41GM066326 · NIGMS · UNIVERSITY OF WISCONSIN-MADISON · PI MARKLEY, JOHN L · 2002 to 2006
$5.0M
CRYOPROBE ACCESSORY FOR A 600 MHZ NMR SPECTROMETER: BIOCHEMISTRY, MICROBIOLOGYS10RR021064 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI KRISHNA, NEPALLI RAMA · 2006 to 2006
$268k
Functional Characterization of the Site Specific Residues in Mutacin 1140R15AI079897 · NIAID · MISSISSIPPI STATE UNIVERSITY · PI SMITH, JAMES LEIF · 2008 to 2009
$245k
WIDE-BORE 9.4 TESLA NMR SPECTROMETER FOR UW-MADISONS10RR002781 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI MARKLEY, JOHN L · 1986 to 1986
–
MASS SPECTROMETER FOR BIOMEDICAL RESEARCHS10RR006487 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DURANT, JOHN R · 1991 to 1991
–
CONSOLE UPGRADES FOR NMR FACILITYS10RR008438 · NCRR · UNIVERSITY OF WISCONSIN MADISON · PI MARKLEY, JOHN L · 1993 to 1993
–
MICROMASS HYBRID QUADRUPOLE--TOF MASS SPECTROMETERS10RR013795 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BARNES, STEPHEN · 1999 to 1999
–
NCI NIH HHS 5P30CA13148NCI NIH HHS P30 CA013148NCI NIH HHS P30 CA13148NCRR NIH HHS 1S10RR021064-01A1NCRR NIH HHS P41 RR002301NCRR NIH HHS P41RR02301NCRR NIH HHS RR06487NCRR NIH HHS RR13795NCRR NIH HHS S10 RR002781NCRR NIH HHS S10 RR006487NCRR NIH HHS S10 RR008438NCRR NIH HHS S10 RR021064NIAID NIH HHS R15 AI079897NIGMS NIH HHS P41 GM066326NIGMS NIH HHS P41GM66326
6 · The paper itself

Abstract

Bacterial strain Burkholderia contaminans MS14 was isolated from soil that suppressed brown patch disease of lawn grass. An antifungal compound was purified from the liquid culture of this bacterium. In this study, complete covalent structures of two purified closely related antifungal compounds were determined by the experiments of TOCSY, NOESY, ROESY, 13C HSQC 2D NMR, and ESI-MS and GC. The analysis of monoisotopic masses of the purified preparation indicated the presence of two related compounds with masses determined to be 1199.543 and 1215.518 Da; the difference corresponds to the mass of an oxygen atom. GC analysis identified a xylose sugar attached to the antifungal compound. NMR experiments revealed that the compound is cyclic and composed of eight amino acids, two of which are beta-hydroxy derivatives of Tyr and Asn, and one being a novel amino acid. The novel amino acid serves as the scaffold for the attachment of the xylose and a short acyl chain. The spectrum and concentration of antifungal activity were determined using a microtiter plate assay. The antifungal compound demonstrated potent antifungal activities against a broad panel of fungal plant and animal pathogens, as well as two Pythium spp. Microscopic observations showed that the antifungal compound disrupts normal membrane morphology. The cells fill with large inclusion bodies and the membrane becomes irregularly shaped and swollen following the exposure to subinhibitory concentrations of the antifungal compound. Our data support the identification of a novel fungicide and the compound has been named occidiofungin, meaning fungal killer.

Indexed as

Antifungal AgentsBurkholderiaFungiGlycopeptidesMicrobial Sensitivity TestsMolecular WeightPlant DiseasesRNA, Ribosomal, 16SSequence Analysis, DNAAntifungal AgentsGlycopeptidesRNA, Ribosomal, 16S

Identifiers

PMID19673482
PMCPMC2771368
OpenAlexW4230320438

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.